Akso Health Group (NASDAQ:AHG) Stock Falls 8.2% – Time to Sell?

Akso Health Group Sponsored ADR (NASDAQ:AHG)’s stock price traded down 8.2% during trading on Thursday. The stock traded as low as $1.30 and last traded at $1.2950. 679 shares changed hands during trading, a decline of 99% from the average session volume of 80,391 shares. The stock had previously closed at $1.41.

Analysts Set New Price Targets

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Akso Health Group in a report on Thursday, October 15th. One analyst has rated the stock with a Sell rating. According to data from MarketBeat.com, the company presently has a consensus rating of “Sell”.

Akso Health Group Stock Performance

The stock has a 50 day simple moving average of $1.02 and a 200-day simple moving average of $1.51.

Hedge Funds Weigh In On Akso Health Group

A hedge fund recently bought a new stake in Akso Health Group stock. Citadel Advisors LLC purchased a new position in Akso Health Group Sponsored ADR (NASDAQ:AHG) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 46,026 shares of the company’s stock, valued at approximately $69,000. Institutional investors and hedge funds own 1.21% of the company’s stock.

Akso Health Group Company Profile

Akso Health Group Limited is a Cayman Islands holding company that operates through subsidiaries in China. The company is focused on the health and wellness sector, offering products and services intended to support consumers’ healthcare, nutrition and general well-being needs.

Akso Health Group’s activities include the distribution and sale of health-related products, including nutritional supplements and other wellness offerings, together with related health management and support services.